2011
DOI: 10.1111/j.1476-5381.2010.01157.x
|View full text |Cite
|
Sign up to set email alerts
|

Inhibition of fatty acid amide hydrolase unmasks CB1 receptor and TRPV1 channel‐mediated modulation of glutamatergic synaptic transmission in midbrain periaqueductal grey

Abstract: BACKGROUND AND PURPOSEWhile arachidonyl ethanolamine (anandamide) produces pharmacological effects mediated by cannabinoid CB1 receptors, it is also an agonist at the transient receptor potential vanilloid type 1 (TRPV1) ion channel. This study examined the cellular actions of anandamide in the midbrain periaqueductal grey (PAG), a region implicated in the analgesic actions of cannabinoids, and which expresses both CB1 receptors and TRPV1. EXPERIMENTAL APPROACHIn vitro whole cell patch clamp recordings of glut… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
44
0
1

Year Published

2012
2012
2024
2024

Publication Types

Select...
5
2
1

Relationship

0
8

Authors

Journals

citations
Cited by 64 publications
(46 citation statements)
references
References 53 publications
1
44
0
1
Order By: Relevance
“…AM6701 afforded greater protection against the excitotoxic events than AM6702, an inhibitor more potent toward FAAH than MAGL. Blocking endocannabinoid deactivation mechanisms represents an exploitable avenue for reducing excitotoxic damage through dual targeting of pharmacotherapeutic pathways [13,[45][46][47][48]. Blocking the inactivation of endocannabinoid responses is 1 such strategy to promote protective signaling after pathological injury and ameliorate cellular disturbances associated with excitotoxicity.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…AM6701 afforded greater protection against the excitotoxic events than AM6702, an inhibitor more potent toward FAAH than MAGL. Blocking endocannabinoid deactivation mechanisms represents an exploitable avenue for reducing excitotoxic damage through dual targeting of pharmacotherapeutic pathways [13,[45][46][47][48]. Blocking the inactivation of endocannabinoid responses is 1 such strategy to promote protective signaling after pathological injury and ameliorate cellular disturbances associated with excitotoxicity.…”
Section: Discussionmentioning
confidence: 99%
“…A bifunctional effect is perhaps occurring in which basal AMPA signals are enhanced through kinase activity, whereas excitotoxic activation of glutamate receptors is reduced through the positive modulation of cannabinergic signaling. An alternative bifunctional mechanism for the modulation of glutamatergic transmission has been proposed, mediated by the inhibition of FAAH [46]. The protective nature of AM6701 that influences the synapse is key, in which preservation of presynaptic and postsynaptic integrity likely explains the corresponding protection at the Fig.…”
Section: Discussionmentioning
confidence: 99%
“…This results in glutamate release in the rostral ventromedial medulla (RVM) and activation of OFF neurons in this area, with subsequent anti-nociception. Furthermore, pre-synaptic TRPV1 activation by endovanilloids stimulates glutamate release also in the PAG [104], which results in the facilitation of metabotropic glutamate receptor-induced impairment of GABA release via endocannabinoids acting in a retrograde and CB1-mediated manner, and again stimulates the descending anti-nociceptive pathway [105].…”
Section: Anandamide Dual Actions At Cb1 and Trpv1 As A 'Plastic' Way mentioning
confidence: 99%
“…promote prolonged neurotransmitter release from the terminals (Medvedeva et al, 2008). and in several brain regions (Gibson et al, 2008;Maione et al, 2009;Kawahara et al, 2011see Edwards, 2014& Ryskamp et al, 2014 such as the hippocampus (Gibson et al, 2008). This process shapes pain receptor sensitization in the peripheral nervous system (Medvedeva et al, 2008) and long-term potentiation for memory formation in the hippocampus (Gibson et al, 2008).…”
Section: Trpv1 Likely Enhances Sensitivity In the Rod Pathway Via Amamentioning
confidence: 99%
“…In the CNS, TRPV1 is likely gated by endovanilloids such as anandamide (Gibson et al, 2008;Maione et al, 2011;Kawahara et al, 2011;Ryskamp et al, 2014). In both LTP and LTD, TRPV1 activation by anandamide results in Ca 2+ influx, prolonged increases in intracellular [Ca 2+ ], and subsequent sustained neurotransmitter release from presynaptic terminals.…”
Section: Introductionmentioning
confidence: 99%